Clathrin-mediated endocytosis of gold nanoparticles in vitro

Anatomical Record

Volumn 298, Issue 2, 2015, Pages 418-427

  Ng, Cheng Teng ^a   Tang, Florence Mei Ai ^a   Li, Jasmine Jia'en ^a   Ong, Cynthia ^a   Yung, Lanry Lin Yue ^b   Bay, Boon Huat ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Autometallography; Clathrin mediated endocytosis; Endocytosis inhibitors; Gold nanoparticles; Transmission microscopy

Indexed keywords

CHLORPROMAZINE; CLATHRIN; CONCANAVALIN A; GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

ARTICLE; CELL SURFACE; CYTOPLASM VESICLE; ENDOCYTOSIS; FETAL BOVINE SERUM; IN VITRO STUDY; LIVER CELL; LUNG FIBROBLAST; MASS SPECTROMETRY; MICROSCOPY; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SERUM; CELL LINE; CELL SURVIVAL; CHEMISTRY; FIBROBLAST; HUMAN; METABOLISM; PHYSIOLOGY;

CELL LINE; CELL SURVIVAL; CLATHRIN; ENDOCYTOSIS; FIBROBLASTS; GOLD; HUMANS; METAL NANOPARTICLES;

EID: 84920982300     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.23051     Document Type: Article

References (48)

1. Alkilany AM, Murphy CJ. 2010. Toxicity and cellular uptake of gold nanoparticles: what have we learned so far? J Nanopart Res 12:2313-2333.
2. Ashley CE, Carnes EC, Phillips GK, Padilla D, Durfee PN, Brown PA, Hanna TN, Liu J, Phillips B, Carter MB, Carroll NJ, Jiang X, Dunphy DR, Willman CL, Petsev DN, Evans DG, Parikh AN, Chackerian B, Wharton W, Peabody DS, Brinker CJ. 2011. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 10:389-397.
3. Boisselier E, Astruc D. 2009. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 38:1759-1782.
4. Brandenberger C, Muhlfeld C, Ali Z, Lenz AG, Schmid O, Parak WJ, Gehr P, Rothen-Rutishauser B. 2010. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles. Small 6:1669-1678.
5. Caruthers SD, Wickline SA, Lanza GM. 2007. Nanotechnological applications in medicine. Curr Opin Biotechnol 18:26-30.
6. Chithrani DB. 2010. Intracellular uptake, transport, and processing of gold nanostructures. Mol Membr Biol 27:299-311.
7. Chithrani DB, Chan WC. 2007. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542-1550.
8. Chithrani DB, Ghazani AA, Chan WC. 2006. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662-668.
9. Cho EC, Au L, Zhang Q, Xia Y. 2010. The effects of size, shape, and surface functional group of gold nanostructures on their adsorption and internalization by cells. Small 6:517-522.
10. dos Santos T, Varela J, Lynch I, Salvati A, Dawson KA. 2011. Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One 6:e24438.
11. Gao H, Yang Z, Zhang S, Cao S, Shen S, Pang Z, Jiang X. 2013. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci Rep 3:2534.
12. Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, Stoter M, Epstein-Barash H, Zhang L, Koteliansky V, Fitzgerald K, Fava E, Bickle M, Kalaidzidis Y, Akinc A, Maier M, Zerial M. 2013. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat Biotechnol 31:638-646.
13. Hao X, Wu J, Shan Y, Cai M, Shang X, Jiang J, Wang H. 2012. Caveolae-mediated endocytosis of biocompatible gold nanoparticles in living Hela cells. J Phys Condens Matter 24:164207.
14. Jiang W, Kim BY, Rutka JT, Chan WC. 2008. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol 3:145-150.
15. Jin H, Heller DA, Sharma R, Strano MS. 2009. Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 3:149-158.
16. Khlebtsov N, Dykman L. 2011. Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev 40:1647-1671
17. Li JJ, Zou L, Hartono D, Ong CN, Bay BH, Yung LY. 2008. Gold nanoparticles induce oxidative damage in lung fibroblasts in vitro. Adv Mater 20:138-142.
18. Li JJ, Hartono D, Ong CN, Bay BH, Yung LY. 2010. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 31:5996-6003.
19. Libutti SK, Paciotti GF, Byrnes AA, Alexander HR Jr, Gannon WE, Walker M, Seidel GD, Yuldasheva N, Tamarkin L. 2010. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res 16:6139-6149.
20. Liu Y, Miyoshi H, Nakamura M. 2007. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles. Int J Cancer 120:2527-2537.
21. Lynch I, Salvati A, Dawson KA. 2009. Protein-nanoparticle interactions: what does the cell see? Nat Nanotechnol 4:546-547.
22. Morisco C, Marrone C, Galeotti J, Shao D, Vatner DE, Vatner SF, Sadoshima J. 2008. Endocytosis machinery is required for beta1-adrenergic receptor-induced hypertrophy in neonatal rat cardiac myocytes. Cardiovasc Res 78:36-44.
23. Mukherjee S, Ghosh RN, Maxfield FR. 1997. Endocytosis. Physiol Rev 77:759-803.
24. Munoz A, Costa M. 2012. Elucidating the mechanisms of nickel compound uptake: a review of particulate and nano-nickel endocytosis and toxicity. Toxicol Appl Pharmacol 260:1-16.
25. Murphy CJ, Gole AM, Stone JW, Sisco PN, Alkilany AM, Goldsmith EC, Baxter SC. 2008. Gold nanoparticles in biology: beyond toxicity to cellular imaging. Acc Chem Res 41:1721-1730.
26. Nam HY, Kwon SM, Chung H, Lee SY, Kwon SH, Jeon H, Kim Y, Park JH, Kim J, Her S, Oh YK, Kwon IC, Kim K, Jeong SY. 2009. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles. J Control Release 135:259-267.
27. Nativo P, Prior IA, Brust M. 2008. Uptake and intracellular fate of surface modified gold nanoparticles. ACS Nano 2:1639-1644.
28. Ng CT, Dheen ST, Yip WC, Ong CN, Bay BH, Lanry Yung LY. 2011. The induction of epigenetic regulation of PROS1 gene in lung fibroblasts by gold nanoparticles and implications for potential lung injury. Biomaterials 32:7609-7615.
29. Ng CT, Li JJ, Gurung RL, Hande MP, Ong CN, Bay BH, Yung LY. 2013. Toxicological profile of small airway epithelial cells exposed to gold nanoparticles. Exp Biol Med (Maywood) 238:1355-1361.
30. Papakonstanti EA, Stournaras C. 2008. Cell responses regulated by early reorganization of actin cytoskeleton. FEBS Lett 582:2120-2127.
31. Pelkmans L, Burli T, Zerial M, Helenius A. 2004. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118:767-780.
32. Pirollo KF, Chang EH. 2008. Does a targeting ligand influence nanoparticle tumor localization or uptake? Trends Biotechnol 26:552-558.
33. Pissuwan D, Valenzuela SM, Cortie MB. 2006. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol 24:62-67.
34. Rattanapinyopituk K, Shimada A, Morita T, Sakurai M, Asano A, Hasegawa T, Inoue K, Takano H. 2014. Demonstration of the clathrin- and caveolin-mediated endocytosis at the maternal-fetal barrier in mouse placenta after intravenous administration of gold nanoparticles. J Vet Med Sci 76:377-387.
35. Rejman J, Oberle V, Zuhorn IS, Hoekstra D. 2004. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 377:159-169.
36. Rothen-Rutishauser B, Kuhn DA, Ali Z, Gasser M, Amin F, Parak WJ, Vanhecke D, Fink A, Gehr P, Brandenberger C. 2013. Quantification of gold nanoparticle cell uptake under controlled biological conditions and adequate resolution. Nanomedicine (Lond) 9:607-621.
37. Singh RD, Puri V, Valiyaveettil JT, Marks DL, Bittman R, Pagano RE. 2003. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol Cell 14:3254-3265.
38. Smith PJ, Giroud M, Wiggins HL, Gower F, Thorley JA, Stolpe B, Mazzolini J, Dyson RJ, Rappoport JZ. 2012. Cellular entry of nanoparticles via serum sensitive clathrin-mediated endocytosis, and plasma membrane permeabilization. Int J Nanomed 7:2045-2055.
39. Sohrab S, Petrusca DN, Lockett AD, Schweitzer KS, Rush NI, Gu Y, Kamocki K, Garrison J, Petrache I. 2009. Mechanism of alpha-1 antitrypsin endocytosis by lung endothelium. FASEB J 23:3149-3158.
40. Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R, Schlenk F, Fischer D, Kiouptsi K, Reinhardt C, Landfester K, Schild H, Maskos M, Knauer SK, Stauber RH. 2013. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772-781.
41. Treuel L, Jiang X, Nienhaus GU. 2013. New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 10:20120939.
42. Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, De Smedt SC, Sanders NN, Braeckmans K. 2010. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther 18:561-569.
43. Wang LH, Rothberg KG, Anderson RG. 1993. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol 123:1107-1117.
44. Wang SH, Lee CW, Chiou A, Wei PK. 2010. Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J Nanobiotechnol 8:33.
45. Wileman T, Harding C, Stahl P. 1985. Receptor-mediated endocytosis. Biochem J 232:1-4.
46. Xin H, Jiang X, Gu J, Sha X, Chen L, Law K, Chen Y, Wang X, Jiang Y, Fang X. 2011. Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma. Biomaterials 32:4293-4305.
47. Yang L, Shang L, Nienhaus GU. 2013. Mechanistic aspects of fluorescent gold nanocluster internalization by live HeLa cells. Nanoscale 5:1537-1543.
48. Yumoto R, Suzuka S, Oda K, Nagai J, Takano M. 2012. Endocytic uptake of FITC-albumin by human alveolar epithelial cell line A549. Drug Metab Pharmacokinet 27:336-343.